1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow A 503: new trials by email Literature Review of A 503 trials Research Report on A 503
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer ADXS-503, Pembrolizumab - Lung Cancer, Non-Small Cell, Metastatic Squamous Cell Carcinoma | Phase 1 / Phase 2 | Completed | Advaxis, Inc. | 24 | 2019-02-12 | 2024-06-04 |
Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Squamous Cell (1)
Advaxis, Inc. (1)
United States (1)
Surya Vangala (1)